马斯克披露全球7人植入脑机接口，脑机概念股延续强势创新医疗连板

Group 1 - The brain-computer interface (BCI) sector is experiencing strong performance, with companies like Innovation Medical and Sairui Medical hitting their daily price limits [1] - Neuralink has successfully implanted BCI devices in 7 individuals, allowing them to interact with external environments through brain signals, including controlling video games [1] - Some participants can control robotic arms for precise tasks, showcasing the potential of BCI technology in medical rehabilitation for patients with spinal cord injuries and ALS [1] Group 2 - Neuralink uses a customized robotic arm for surgery, implanting the N1 chip, which is the size of a coin and collects brain signals via microelectrodes [2] - The BCI technology is considered one of the most disruptive innovations of the 21st century, with significant breakthroughs in recent years, including FDA approval for human trials and advancements from companies like Meta [2] - Domestic companies are actively investing in the BCI field, with Innovation Medical's partner Boling focusing on BCI technology and high-end medical device development, expecting market sales by 2025 [2]